Stryker Corporation (SYK)

Pretax margin

Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 4,514,000 3,337,000 3,351,000 3,333,000 3,492,000 4,190,000 4,016,000 3,917,000 3,673,000 3,208,000 3,155,000 2,976,000 2,683,000 2,679,000 2,358,000 2,300,000 2,281,000 2,195,000 2,480,000 1,731,000
Revenue (ttm) US$ in thousands 25,116,000 24,381,000 23,818,000 23,218,000 22,595,000 21,974,000 21,389,000 20,963,000 20,498,000 19,885,000 19,455,000 18,952,000 18,449,000 17,948,000 17,629,000 17,430,000 17,108,000 16,669,000 16,246,000 14,716,000
Pretax margin 17.97% 13.69% 14.07% 14.36% 15.45% 19.07% 18.78% 18.69% 17.92% 16.13% 16.22% 15.70% 14.54% 14.93% 13.38% 13.20% 13.33% 13.17% 15.27% 11.76%

December 31, 2025 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $4,514,000K ÷ $25,116,000K
= 17.97%


Peer comparison

Dec 31, 2025

Company name
Symbol
Pretax margin
Stryker Corporation
SYK
17.97%
Abbott Laboratories
ABT
18.56%
CONMED Corporation
CNMD
6.35%